BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26946613)

  • 21. Local CD4+, CD8+ and CD56+ reactions to lung cancer in regard to pathohistological type and clinical stage.
    Jusufovic E; Iljazovic E; Kosnik M; Keser D; Korosec P; Zukic E; Prnjavorac B; Sejdinović R; Ajanović E
    Med Glas (Zenica); 2011 Feb; 8(1):101-8. PubMed ID: 21263406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
    Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
    Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of Tanreqing injection on immune activity of peripheral blood lymphocytes of patients with lung cancer].
    Ma M; Yang XX; Zhang J; Zhao LM; Liu LH; Shan BE
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1207-11. PubMed ID: 26226772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive immunotherapy for non-small cell lung cancer by NK and cytotoxic T lymphocytes mixed effector cells: retrospective clinical observation.
    Zhang G; Zhao H; Wu J; Li J; Xiang Y; Wang G; Wu L; Jiao S
    Int Immunopharmacol; 2014 Aug; 21(2):396-405. PubMed ID: 24881900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dietary ribonucleotides on infant immune status. Part 2: Immune cell development.
    Buck RH; Thomas DL; Winship TR; Cordle CT; Kuchan MJ; Baggs GE; Schaller JP; Wheeler JG
    Pediatr Res; 2004 Dec; 56(6):891-900. PubMed ID: 15496603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural Killer Group 2A Expressed on Both Peripheral CD3
    Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
    J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Short term therapeutic effect on treatment of postoperational large intestine carcinoma by Fupiyiwei decoction combined with chemotherapy and it's effect on immune function].
    Wu G; Yu G; Li J; Xiong F
    Zhongguo Zhong Yao Za Zhi; 2010 Mar; 35(6):782-5. PubMed ID: 20545209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman J; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):997-1006. PubMed ID: 11072156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
    Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
    Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.
    Hirose T; Yamaoka T; Ohnishi T; Sugiyama T; Kusumoto S; Shirai T; Okuda K; Ohmori T; Adachi M
    Psychooncology; 2009 May; 18(5):483-9. PubMed ID: 18942662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
    Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
    J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating T-Cell Subsets, Monocytes, and Natural Killer Cells in Peripartum Cardiomyopathy: Results From the Multicenter IPAC Study.
    McTiernan CF; Morel P; Cooper LT; Rajagopalan N; Thohan V; Zucker M; Boehmer J; Bozkurt B; Mather P; Thornton J; Ghali JK; Hanley-Yanez K; Fett J; Halder I; McNamara DM;
    J Card Fail; 2018 Jan; 24(1):33-42. PubMed ID: 29079307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical study evaluating dendritic and cytokine-induced killer cells combined with concurrent radiochemotherapy for stage IIIB non-small cell lung cancer.
    Zhu XP; Xu YH; Zhou J; Pan XF
    Genet Mol Res; 2015 Aug; 14(3):10228-35. PubMed ID: 26345959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behçet's disease.
    Kibaroglu A; Eksioglu-Demiralp E; Akoglu T; Direskeneli H
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S59-63. PubMed ID: 15515788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular immune profile in patients with non-small cell lung cancer after weekly paclitaxel therapy.
    Sako T; Burioka N; Yasuda K; Tomita K; Miyata M; Kurai J; Chikumi H; Watanabe M; Suyama H; Fukuoka Y; Ueda Y; Shimizu E
    Acta Oncol; 2004; 43(1):15-9. PubMed ID: 15068315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
    Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
    Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
    Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
    Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Enhancing effect of compound Kusheng injection in combination with chemotherapy for patients with advanced non-small cell lung cancer].
    Fan CX; Lin CL; Liang L; Zhao YY; Liu J; Cui J; Yang QM; Wang YL; Zhang AR
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):294-7. PubMed ID: 20510083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancer.
    Wang M; Cao JX; Pan JH; Liu YS; Xu BL; Li D; Zhang XY; Li JL; Liu JL; Wang HB; Wang ZX
    PLoS One; 2014; 9(11):e112662. PubMed ID: 25412106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
    Sakamoto M; Mikasa K; Hamada K; Konishi M; Maeda K; Yoshimoto E; Ueda K; Majima T; Sawaki M; Kita E; Narita N
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2259-66. PubMed ID: 9881083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.